Sale!

NTRK1 Gene Fusion Test

Original price was: $300.Current price is: $226.

-25%

The NTRK1 Gene Fusion Test is a specialized molecular diagnostic examination that identifies NTRK1 gene rearrangements in tumor tissue samples. This advanced FISH-based test detects specific genetic alterations that can drive cancer development and progression. The test is particularly valuable for patients with various solid tumors who may benefit from targeted therapies. By identifying NTRK1 fusions, healthcare providers can determine eligibility for TRK inhibitor treatments that specifically target these genetic abnormalities. The test requires paraffin-embedded tissue blocks and provides results within 7-8 days. Priced at $226 USD, this test offers critical information for personalized cancer treatment planning and therapeutic decision-making.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

NTRK1 Gene Fusion Test: Comprehensive Genetic Analysis for Targeted Cancer Therapy

Understanding the NTRK1 Gene Fusion Test

The NTRK1 Gene Fusion Test represents a cutting-edge advancement in precision oncology, offering crucial insights into cancer genetics that can significantly impact treatment decisions. This specialized diagnostic examination utilizes Fluorescence In Situ Hybridization (FISH) technology to detect NTRK1 gene rearrangements in tumor tissue samples. The neurotrophic tyrosine receptor kinase 1 (NTRK1) gene plays a vital role in normal cellular development and function, but when fused with other genes, it can become a powerful driver of cancer growth and progression.

What Does the NTRK1 Test Measure?

The NTRK1 Gene Fusion Test specifically detects:

  • NTRK1 gene rearrangements and fusions
  • Chromosomal abnormalities involving the NTRK1 locus
  • Genetic alterations that create oncogenic fusion proteins
  • Specific biomarker patterns indicating TRK inhibitor responsiveness

Who Should Consider NTRK1 Testing?

This test is particularly recommended for patients with:

  • Various solid tumors including salivary gland, thyroid, and soft tissue cancers
  • Pediatric cancers with unknown genetic drivers
  • Advanced or metastatic cancers requiring targeted therapy options
  • Rare tumor types where conventional treatments have shown limited efficacy
  • Patients seeking comprehensive genetic profiling for personalized treatment planning

Clinical Indications and Symptoms

Patients experiencing persistent symptoms or diagnosed with cancers that may harbor NTRK fusions should consider this test. These include individuals with treatment-resistant tumors, rare cancer subtypes, or those seeking alternative therapeutic approaches when standard treatments prove ineffective.

Benefits of NTRK1 Gene Fusion Testing

  • Precision Treatment Guidance: Identifies eligibility for targeted TRK inhibitor therapies
  • Personalized Cancer Care: Enables tailored treatment strategies based on genetic profile
  • Improved Outcomes: Helps select therapies with higher likelihood of success
  • Comprehensive Genetic Insight: Provides valuable information for treatment decision-making
  • Advanced Diagnostic Capability: Utilizes sophisticated FISH technology for accurate detection

Understanding Your Test Results

Your NTRK1 test results will provide clear information about the presence or absence of NTRK1 gene fusions:

  • Positive Result: Indicates the presence of NTRK1 fusion, suggesting potential responsiveness to TRK inhibitor therapies
  • Negative Result: No NTRK1 fusion detected, guiding consideration of alternative treatment approaches
  • Inconclusive Result: May require additional testing or sample collection

All results should be discussed with your healthcare provider who can interpret them in the context of your specific medical situation and treatment goals.

Test Information and Pricing

Test Parameter Details
Test Name NTRK1 Gene Fusion Test
Discount Price $226 USD
Regular Price $300 USD
Turnaround Time 7-8 Days
Sample Type Tumor Tissue
Test Components Paraffin Embedded Tissue Blocks
Testing Method FISH (Fluorescence In Situ Hybridization)

Pre-Test Instructions

The NTRK1 Gene Fusion Test requires a doctor’s prescription for most cases. Prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel. Please consult with your healthcare provider to determine if this test is appropriate for your specific medical needs.

Nationwide Testing Availability

General Genetics Corporation provides comprehensive NTRK1 testing services across the United States. We have established branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, high-quality genetic testing services for patients throughout the country.

Take the Next Step in Your Cancer Care Journey

Don’t leave your treatment decisions to chance. The NTRK1 Gene Fusion Test provides critical genetic information that can guide your cancer treatment strategy. With our discounted price of $226 USD and comprehensive testing capabilities, you can access advanced genetic insights that may significantly impact your treatment outcomes.

Ready to schedule your NTRK1 Gene Fusion Test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and help you navigate the testing process with confidence and clarity.